|1||Not yet recruiting||
Incidence of Significant Mitral Regurgitation in Acute Heart Failure Patients
Dabigatran Versus Warfarin After Mitral and/or Aortic Bioprosthesis Replacement and Atrial Fibrillation Postoperatively
Management and Clinical Outcomes of Patients With Severe Mitral Valve Disease Not Suitable for Surgery
Observatory of Anticoagulation After Bioprosthetic Aortic Valve Replacement
|5||Not yet recruiting||
Lp(a) and Aortic Valve Calcification
† Study has passed its completion date and status has not been verified in more than two years.